Cargando…
Protection Evaluation of a Five-Gene-Deleted African Swine Fever Virus Vaccine Candidate Against Homologous Challenge
African swine fever virus (ASFV) represents a serious threat to the global swine industry, and there are no safe or commercially available vaccines. Previous studies have demonstrated that inactivated vaccines do not provide sufficient protection against ASFV and that attenuated vaccines are effecti...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374035/ https://www.ncbi.nlm.nih.gov/pubmed/35966648 http://dx.doi.org/10.3389/fmicb.2022.902932 |
_version_ | 1784767709738696704 |
---|---|
author | Xie, Zhenhua Liu, Yingnan Di, Dongdong Liu, Jingyi Gong, Lang Chen, Zongyan Li, Yao Yu, Wanqi Lv, Lu Zhong, Qiuping Song, Yingying Liao, Xinxin Song, Qingqing Wang, Heng Chen, Hongjun |
author_facet | Xie, Zhenhua Liu, Yingnan Di, Dongdong Liu, Jingyi Gong, Lang Chen, Zongyan Li, Yao Yu, Wanqi Lv, Lu Zhong, Qiuping Song, Yingying Liao, Xinxin Song, Qingqing Wang, Heng Chen, Hongjun |
author_sort | Xie, Zhenhua |
collection | PubMed |
description | African swine fever virus (ASFV) represents a serious threat to the global swine industry, and there are no safe or commercially available vaccines. Previous studies have demonstrated that inactivated vaccines do not provide sufficient protection against ASFV and that attenuated vaccines are effective, but raise safety concerns. Here, we first constructed a deletion mutant in which EP153R and EP402R gene clusters were knocked out. Based on the deletion mutant, a further deletion from the MGF_360-12L, MGF_360-13L to MGF_360-14L genes was obtained. The five-genes knockout virus was designated as ASFV-ΔECM3. To investigate the efficacy and safety of the ASFV-ΔECM3 virus as a vaccine candidate, the evaluation of the virus was subsequently carried out in pigs. The results showed that the ASFV-ΔECM3 virus could induce homologous protection against the parental isolate, and no significant clinical signs or viremia were observed. These results show that the contiguous deletion mutant, ASFV-ΔECM3 encompassing the EP153R/EP402R and MGF_360-12L/13L/14L genes, could be a potential live-attenuated vaccine candidate for the prevention of ASFV infection. |
format | Online Article Text |
id | pubmed-9374035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93740352022-08-13 Protection Evaluation of a Five-Gene-Deleted African Swine Fever Virus Vaccine Candidate Against Homologous Challenge Xie, Zhenhua Liu, Yingnan Di, Dongdong Liu, Jingyi Gong, Lang Chen, Zongyan Li, Yao Yu, Wanqi Lv, Lu Zhong, Qiuping Song, Yingying Liao, Xinxin Song, Qingqing Wang, Heng Chen, Hongjun Front Microbiol Microbiology African swine fever virus (ASFV) represents a serious threat to the global swine industry, and there are no safe or commercially available vaccines. Previous studies have demonstrated that inactivated vaccines do not provide sufficient protection against ASFV and that attenuated vaccines are effective, but raise safety concerns. Here, we first constructed a deletion mutant in which EP153R and EP402R gene clusters were knocked out. Based on the deletion mutant, a further deletion from the MGF_360-12L, MGF_360-13L to MGF_360-14L genes was obtained. The five-genes knockout virus was designated as ASFV-ΔECM3. To investigate the efficacy and safety of the ASFV-ΔECM3 virus as a vaccine candidate, the evaluation of the virus was subsequently carried out in pigs. The results showed that the ASFV-ΔECM3 virus could induce homologous protection against the parental isolate, and no significant clinical signs or viremia were observed. These results show that the contiguous deletion mutant, ASFV-ΔECM3 encompassing the EP153R/EP402R and MGF_360-12L/13L/14L genes, could be a potential live-attenuated vaccine candidate for the prevention of ASFV infection. Frontiers Media S.A. 2022-07-29 /pmc/articles/PMC9374035/ /pubmed/35966648 http://dx.doi.org/10.3389/fmicb.2022.902932 Text en Copyright © 2022 Xie, Liu, Di, Liu, Gong, Chen, Li, Yu, Lv, Zhong, Song, Liao, Song, Wang and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Xie, Zhenhua Liu, Yingnan Di, Dongdong Liu, Jingyi Gong, Lang Chen, Zongyan Li, Yao Yu, Wanqi Lv, Lu Zhong, Qiuping Song, Yingying Liao, Xinxin Song, Qingqing Wang, Heng Chen, Hongjun Protection Evaluation of a Five-Gene-Deleted African Swine Fever Virus Vaccine Candidate Against Homologous Challenge |
title | Protection Evaluation of a Five-Gene-Deleted African Swine Fever Virus Vaccine Candidate Against Homologous Challenge |
title_full | Protection Evaluation of a Five-Gene-Deleted African Swine Fever Virus Vaccine Candidate Against Homologous Challenge |
title_fullStr | Protection Evaluation of a Five-Gene-Deleted African Swine Fever Virus Vaccine Candidate Against Homologous Challenge |
title_full_unstemmed | Protection Evaluation of a Five-Gene-Deleted African Swine Fever Virus Vaccine Candidate Against Homologous Challenge |
title_short | Protection Evaluation of a Five-Gene-Deleted African Swine Fever Virus Vaccine Candidate Against Homologous Challenge |
title_sort | protection evaluation of a five-gene-deleted african swine fever virus vaccine candidate against homologous challenge |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374035/ https://www.ncbi.nlm.nih.gov/pubmed/35966648 http://dx.doi.org/10.3389/fmicb.2022.902932 |
work_keys_str_mv | AT xiezhenhua protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT liuyingnan protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT didongdong protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT liujingyi protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT gonglang protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT chenzongyan protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT liyao protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT yuwanqi protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT lvlu protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT zhongqiuping protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT songyingying protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT liaoxinxin protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT songqingqing protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT wangheng protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge AT chenhongjun protectionevaluationofafivegenedeletedafricanswinefevervirusvaccinecandidateagainsthomologouschallenge |